GOLDEN GATE PRIVATE EQUITY, INC.

13F Filings History

Latest 13F report
Q2 2024 - Aug 7, 2024
Value $
$0
Signature - Title
David C. Dominik - Director
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by GOLDEN GATE PRIVATE EQUITY, INC.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GOLDEN GATE PRIVATE EQUITY, INC. didn't report any stock holdings as of Q2 2024.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 0 $0 $0 $0 13F-HR 8/7/2024, 11:46 AM
Q1 2024 0 $0 $0 $0 13F-HR 5/14/2024, 10:31 AM
Q4 2023 0 $0 $0 -$241M -$241M 13F-HR 2/14/2024, 03:13 PM
Q3 2023 2 $241M $0 -$611K -$611K LVOX, SAMG 13F-HR 11/14/2023, 11:15 AM
Q2 2023 3 $199M $0 $0 LVOX, ABST, SAMG 13F-HR 8/14/2023, 03:33 PM
Q1 2023 3 $223M $0 $0 LVOX, ABST, SAMG 13F-HR 5/15/2023, 01:32 PM
Q4 2022 3 $215M $0 -$2.05M -$2.05M LVOX, ABST, SAMG 13F-HR 2/14/2023, 03:05 PM
Q3 2022 4 $216M $0 -$12.5M -$12.5M LVOX, AVTA, ABST, SAMG 13F-HR 11/14/2022, 02:02 PM
Q2 2022 4 $134M $0 -$2 -$2 LVOX, AVTA, ABST, SAMG 13F-HR 8/15/2022, 06:07 PM
Q1 2022 4 $218M +$14.1M -$139M -$125M LVOX, AVTA, ABST, SAMG 13F-HR 5/16/2022, 08:48 PM
Q4 2021 6 $498M +$1.97M $0 +$1.97M LVOX, CNR, AVTA, ETWO, ABST 13F-HR 2/14/2022, 08:16 PM
Q3 2021 6 $565M +$2.56M -$85.9M -$83.3M LVOX, CNR, AVTA, ETWO, ABST 13F-HR 11/12/2021, 03:06 PM
Q2 2021 14 $798M +$558M -$1.74M +$556M LVOX, CNR, NLSN, VG, AVTA 13F-HR 8/13/2021, 04:28 PM
Q1 2021 14 $206M +$43.1M -$174M -$131M CNR, NLSN, VG, AVTA, AMK 13F-HR 5/17/2021, 10:59 AM
Q4 2020 9 $249M +$33.3M $0 +$33.3M CNR, NLSN, MTSC, AVTA, VG 13F-HR 2/16/2021, 11:37 AM
Q3 2020 5 $172M $0 -$142M -$142M CNR, NLSN, LPSN, MTSC, RAMP 13F-HR 11/13/2020, 02:48 PM
Q2 2020 23 $282M +$14.5M -$11.8M +$2.69M CNR, NLSN, TNET, FI, MORN 13F-HR 8/14/2020, 02:06 PM
Q1 2020 24 $216M +$27.2M -$22.2M +$5.03M CNR, NLSN, FI, VRNT, TNET 13F-HR 5/14/2020, 03:33 PM
Q4 2019 25 $175M $0 $0 NLSN, HXL, FI, TNET, MORN 13F-HR 2/14/2020, 04:10 PM
Q3 2019 25 $297M +$19.9M -$25M -$5.13M CNR, NLSN, HXL, FI, TNET 13F-HR 11/14/2019, 12:47 PM
Q2 2019 24 $301M +$108M -$112M -$3.96M CNR, NLSN, TNET, HXL, ASNA 13F-HR 8/14/2019, 03:46 PM
Q1 2019 24 $310M +$11M -$79.6M -$68.6M NCS, NLSN, ASNA, FDC, TNET 13F-HR 5/14/2019, 03:12 PM
Q4 2018 24 $380M +$203M -$64.4M +$139M NCS, NLSN, ASNA, RAMP, PPBI Restatement 2/28/2019, 08:58 PM
Q3 2018 23 $305M +$131M -$3.39M +$128M ASNA, ACXM, NLSN, FDC, MORN 13F-HR 11/14/2018, 02:32 PM
Q2 2018 22 $163M +$9.21M -$9.21M +$6.79K ASNA, MORN, HXL, TNET, FDC 13F-HR 8/10/2018, 03:09 PM
Q1 2018 22 $121M +$19.3M -$10.6M +$8.65M ASNA, TNET, MORN, HXL, MODN 13F-HR 5/15/2018, 12:10 PM
Q4 2017 21 $119M +$5.75M -$18.6M -$12.9M ASNA, TNET, MORN, KLXI, AWI 13F-HR 2/13/2018, 05:30 PM
Q3 2017 23 $128M +$8.24M -$86.5M -$78.3M ASNA, ARCC, LPSN, MORN, AWI 13F-HR 11/8/2017, 04:58 PM
Q2 2017 23 $195M +$9.58M -$12.4M -$2.8M NSR, ASNA, ARCC, TNET, MORN 13F-HR 8/14/2017, 11:03 AM
Q1 2017 23 $234M +$13.1M -$4.34M +$8.74M NSR, ASNA, ASH, VPG, TNET 13F-HR 5/15/2017, 01:05 PM
Q4 2016 20 $255M +$18.7M -$19.1M -$400K ASNA, NSR, ASH, VPG, TNET 13F-HR 2/14/2017, 09:06 AM
Q3 2016 17 $223M +$69.5M -$19M +$50.4M ASNA, NSR, NGVT, VPG, ABCO 13F-HR 11/14/2016, 01:20 PM
Q2 2016 15 $184M +$35.4M -$90.2M -$54.8M ASNA, NGVT, VPG, ARRS, FIVN 13F-HR 8/15/2016, 08:34 AM
Q1 2016 14 $285M +$5.93M -$6.11M -$187K ASNA, NXPI, VPG, PTC, ALB 13F-HR 5/16/2016, 04:35 PM
Q4 2015 13 $294M +$193M -$104M +$89.8M ASNA, NXPI, ARRS, VPG, PTC 13F-HR 2/16/2016, 08:21 AM
Q3 2015 12 $228M +$107M -$236M -$130M FSL, ASNA, ARRS, VPG, HXL 13F-HR 11/13/2015, 07:57 AM
Q2 2015 10 $371M $0 -$36.6M -$36.6M ANN, FSL, FMSA, ARRS, VPG 13F-HR 8/14/2015, 07:37 AM
Q1 2015 12 $374M +$32.2M -$39.9M -$7.68M ANN, FSL, FMSA, MED, ARCC 13F-HR 5/15/2015, 11:20 AM
Q4 2014 13 $320M +$878K -$31.6M -$30.7M ANN, FSL, NSP, MED, VPG 13F-HR 2/13/2015, 01:56 PM
Q3 2014 19 $355M +$45.9M -$172M -$126M ANN, FSL, NSP, MED, CRRTQ 13F-HR 11/14/2014, 12:13 PM
Q2 2014 20 $495M +$26.2M -$12M +$14.2M ANN, ARX, FSL, MED, ARRS 13F-HR 8/11/2014, 12:00 PM
Q1 2014 17 $448M +$187M -$26.6M +$160M ANN, ARX, FSL, MED, DLLR 13F-HR 5/13/2014, 01:34 PM
Q4 2013 18 $235M $0 $0 ARX, FSL, ARRS, DLLR, MED 13F-HR 2/13/2014, 07:30 PM